More Medical Articles

Medical

COVID-19: A data challenge and a catalyst for new insights

Andrew Stone, (Nov 24, 2020)

The healthcare ecosystem has demonstrated its ability to share data to uncover new insights this year but there is more to be done, says Nigel Hughes, scientific director at Epidemiology, Janssen R&D
Access and Evidence

Survey results: Accelerating digital transformation during COVID-19

Nicola Davies, (Sep 4, 2020)

View the results of a survey of over 1000 pharma executives on the impact COVID-19 has had and will have on their operations
Medical

Paying for cell and gene therapy - Is the future already here?

Ulrich Neumann, (Aug 25, 2020)

Multiple novel payment models for CGT are in development but an open and collaborative approach among all healthcare stakeholders is needed if the significant legal and practical barriers are to be overcome
Medical

The age of the digital opinion leader

Andrew Stone, (Jul 28, 2020)

Key opinion leaders who evolve into the digital sphere to become digital opinion leaders will gain more reach and influence
Medical

The key to digital innovation: The human touch

Andrew Stone, (Jun 30, 2020)

Takeda is building on strong stakeholder relationships it has nurtured patiently over time to co-create solutions during COVID-19
Medical

Building the medical affairs organisation of tomorrow

Lucy Fulford, (Jun 15, 2020)

As medical affairs increasingly engages with new stakeholders - HTA bodies, regulators and patient groups - it must upskill and upgrade its data and collaboration capabilities
Access and Evidence

From reactive to predictive: Concerto’s new compositions

Andrew Stone, (Apr 10, 2020)

Artificial Intelligence has only just begun to unlock high value innovation. The latest predictive tools will break new ground, says Concerto HealthAI’s Jeff Elton
Medical

Leading the hunt for a COVID-19 vaccine

Andrew Stone, (Apr 1, 2020)

J&J gives the inside track on the search for a COVID-19 vaccine at eyeforpharma’s Barcelona conference
Medical

Medical: Pharma’s New North Star

Tom Disley, (Feb 20, 2020)

Already growing in importance, Medical Affairs will become a key differentiator for pharma campanies prepared to adapt and invest in the function
Access and Evidence

Into pharma's roaring twenties

Paul Simms, (Jan 14, 2020)

A new decade is here. And despite the incredible science, pharma is ill-equipped.

Pages